Pharmstandard International S.A.

Q2 2017 13F Holdings Report, Options Holdings

Signature - Title
Eriks Martinovskis - Director
Location
Luxembourg, Luxembourg
Options holdings as of
30 Jun 2017
Notional value
$1,859,000
Number of holdings
1
Filing time
15 Aug 2017, 17:24:00 UTC
Description
All US holdings of this investor are reported in this report.
Previous filing
Q1 2017 - 17 Aug 2017
Next filing
Q3 2017 - 03 Nov 2017
Stock holdings
Showing options holdings, see here for stock holdings
Sym Company Class Option Share Change Activity * Price $ Shares Notional Value
Filing 2017 Q2 compared to 2017 Q1 - Restatement by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Eriks Martinovskis Director Luxembourg, Luxembourg 15 Aug 2017

Other Included Managers (1):

Num Name Location File Number
1 Joint Stock Co Pharmstandard Dolgoprudny, Russian Federation